CNTA (STOCKS)
Centessa Pharmaceuticals plc American Depositary Shares
$39.570000
+0.090000 (+0.23%)
Prev close: $39.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mario Alberto Accardi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,904.95M
- Employees
- 114
- P/E (TTM)
- -27.16
- P/B (TTM)
- 11.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.48 | $-0.39 | -0.0916 | -23.58% |
|
Sep 2025 (Q3)
|
$-0.41 | $-0.40 | -0.0138 | -3.48% |
|
Jun 2025 (Q2)
|
$-0.38 | $-0.35 | -0.0281 | -7.99% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.38 | +0.1800 | +47.37% |
Financial Statements
| Revenues | $15.00M |
| Benefits Costs and Expenses | $210.71M |
| Costs And Expenses | $210.71M |
| Operating Expenses | $222.69M |
| Operating Income/Loss | -$207.69M |
| Income/Loss From Continuing Operations After Tax | -$197.53M |
| Income/Loss From Continuing Operations Before Tax | -$195.71M |
| Income Tax Expense/Benefit | $1.82M |
| Income Tax Expense/Benefit, Deferred | $2.51M |
| Net Income/Loss | -$197.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$197.53M |
| Net Income/Loss Available To Common Stockholders, Basic | -$197.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.46 |
| Diluted Earnings Per Share | -$1.46 |
| Basic Average Shares | 135,715,608 |
| Diluted Average Shares | 135,715,608 |
| Assets | $687.50M |
| Current Assets | $367.88M |
| Noncurrent Assets | $319.62M |
| Fixed Assets | $807.00K |
| Other Non-current Assets | $318.81M |
| Liabilities | $160.63M |
| Current Liabilities | $42.94M |
| Accounts Payable | $7.58M |
| Wages | $14.47M |
| Other Current Liabilities | $20.89M |
| Noncurrent Liabilities | $117.70M |
| Long-term Debt | $110.10M |
| Other Non-current Liabilities | $7.60M |
| Equity | $526.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $526.86M |
| Liabilities And Equity | $687.50M |
| Net Cash Flow From Operating Activities | -$193.82M |
| Net Cash Flow From Operating Activities, Continuing | -$193.82M |
| Net Cash Flow From Investing Activities | -$418.53M |
| Net Cash Flow From Investing Activities, Continuing | -$418.53M |
| Net Cash Flow From Financing Activities | $291.53M |
| Net Cash Flow From Financing Activities, Continuing | $291.53M |
| Exchange Gains/Losses | -$448.00K |
| Net Cash Flow | -$321.27M |
| Net Cash Flow, Continuing | -$320.82M |
| Comprehensive Income/Loss | -$199.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$199.03M |
| Other Comprehensive Income/Loss | -$199.03M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.50M |